12 Jul 2021
The global asthma spacers market is expected to grow moderately, at a CAGR of 3.9% between 2020 and 2026. The proliferation of respiratory illnesses such as asthma and allergies on back of pollution and smoking is paving the way for high demand growth of asthma spacers. The geriatric population of the world is increasing rapidly and is exhibiting heightened disposition for respiratory disorders. Projections indicate that by 2050, more than one-fifth of the world’s population shall constitute the elderly. Consequently, the number of asthma patients shall increase manifold. The World Health Organization predicts that by the end of 2025, an additional 100 million people shall contract asthma. At present, around 235 million people are affected by asthma. On the back of the aforementioned factors, the market shall surpass a value of US$ 1.8 Bn by the end of the forecast period. Moreover, difficulties using metered dose inhalers (MDI) is expected to further leverage the asthma spacers market.
“The global asthma spacers market shows significant potential in the future. Growing incidence of asthma among the elderly, combined with a burgeoning population are contributing immensely to the expansion of the asthma spacers market,” concludes a Fact.MR analyst.
The global asthma spacers market is highly fragmented. A number of small and large-scale companies operate in the market. The dominant players’ invest heavily in acquiring research and development businesses of smaller companies. Moreover, they also focused on launching new products. For instance, Trudell International invests in continuous innovation in order to broad base its market footprint. Its AEROCHAMBER PLUS FLOW-VU ensures that medicine is delivered where it is required. It consists of a dedicated inhalation indicator which helps co-ordinate actuation with inhalation. Another market player, Medical Developments International, focuses on spontaneous technological innovation to develop patient-friendly markers. For example, the company’s Anti-Static Compact Space Chamber Plus, is equipped with a Cross Valve Technology. This ensures proper delivery of medicine to asthma patients by providing low-resistance, one-way inhalation flow.
The research study on the asthma spacers market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global asthma spacers market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of product type (Aerochambers, Optichambers, Volumatic, Inspirease and Others) and distribution channel (Retail Pharmacy, e-Commerce and Hospital Pharmacy) across five major regions.
Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions. For more information on our deep domain expertise, click here.
Asthma Spacers Market
Free SampleAbout Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. We are known for our syndicated research, custom research, and consulting solutions.